Reckitt Benckiser disappoints but headwinds should ease

Josh White Sharecast | 21 Apr, 2017 08:19 - Updated: 12:01 | | |

Reckitt Benckiser, consumer goods, Cillit Bang, Vanish
  • 7,257.00
  • -1.32%-97.00
  • Max: 7,327.00
  • Min: 7,256.00
  • Volume: 964,592
  • MM 200 : n/a
17:30 18/08/17
  • 7,323.98
  • -0.86%-63.89
  • Max: 7,387.87
  • Min: 7,302.47
  • Volume: 0
  • MM 200 : n/a
17:20 18/08/17
  • 4,070.49
  • -0.84%-34.63
  • Max: 4,105.14
  • Min: 4,059.74
  • Volume: 0
  • MM 200 : n/a
17:25 18/08/17
  • 4,018.66
  • -0.83%-33.71
  • Max: 4,052.39
  • Min: 4,008.78
  • Volume: 0
  • MM 200 : n/a
17:30 18/08/17
  • 18,387.08
  • -0.86%-159.65
  • Max: 18,546.73
  • Min: 18,352.26
  • Volume: 0
  • MM 200 : n/a
17:25 18/08/17

Consumer products group Reckitt Benckiser posted a trading update for its first quarter on Friday, reporting it was in line with expectations with continued strong performance in the health division led by Mucinex and Durex.

However, sales in the quarter were slightly behind analyst consensus as negative like-for-like sales in Europe were offset by growth in developing markets and foods.

The FTSE 100 firm said that growth was offset by headwind in Scholl/Amopé, which also impacted Europe-North America performance.

Growth rates were set to improve through the year, and RB said it was on track for its full year net revenue target of 3% like-for-like.

The company said home and portfolio categories, and the DvM emerging market area, were negatively impacted by what the it called the “Korea HS issue”, whereby it was still dealing with the legacy of faulty Oxy RB-branded humidity sterilisers distributed in the 1990s and 2000s that caused a number of deaths.

The Mead Johnson acquisition remained on track for completion by the end of the third quarter, it added, and confirmed the strategic review of the Food business had commenced.

“Our Q1 results are in line with expectations as macro conditions remain challenging,” said CEO Rakesh Kapoor.

“Against this backdrop our underlying business remains strong.”

Kapoor said RB delivered continued outperformance in consumer health and good growth in DvM, offset by previously flagged headwinds, which would persist during the first half.

“I expect our growth trajectory to improve as we progress through the year and we remain on track to achieve our full year net revenue target of 3% LFL growth.”

Charlie Huggins, a fund manager for Hargreaves Lansdown, said it was the first quarter he can remember where the group has failed to grow its like-for-like sales and that most of the headwinds should ease as the year progresses.

"We don’t think for one minute that Reckitt’s brands are losing their fundamental appeal, or that the company has lost its ability to innovate.

"We expect this brand strength, supported by the company’s huge marketing clout, to drive growth in the longer term. The investment case also depends on Reckitt’s ability to integrate the Mead Johnson acquisition, which is expected to complete at the end of the third quarter."

More news

19:01 Europe close: Stocks edge slightly higher at the end of the session

Stocks pared early losses as traders digested a terrorist attack on Barcelona overnight and monitored the news-flow coming from the White House.

18:04 Weeky review

The FTSE 100 finished the week almost flat, up 14.02 points or 0.19%, at 7,323.98.

17:22 London close: Risk aversion grips FTSE, stocks lower on Trump and Barcelona attacks

London's FTSE 100 index fell below a key technical level as Friday's session wore on, with travel stocks leading the retreat after the terror attacks in Barcelona and the large cabal of overseas focused companies hit by the dollar's weakness amid renewed concerns about the US Presidency.

17:03 BowLeven appoints new director

AIM-listed oil and gas group, BowLeven announced on Friday that Matt McDonald would be appointed to the firm's board as non-executive director with immediate effect.

17:04 Week ahead: Not everything that happens at Jackson Hole stays there

In the coming week, the spotlight will be on the Federal Reserve bank of Kansas City's Symposium in Jackson Hole, Wyoming.

16:26 Acacia remains a 'buy' for HSBC but target price slashed

HSBC cut its target price for Acacia Mining by 47% but kept its 'buy' recommendation in place as the months-long spat with the Tanzanian government still hangs over the company.

16:10 US open: Stocks flat heading into the weekend, political ruckus weighs

Wall Street is essentially flat heading into the weekend after the head of the University of Michigan's consumer confidence survey said recent events in Charlottesville were likely to take their toll on sentiment.

15:18 FTSE 250 movers: Hikma still looking ill; Kaz Minerals buffs up

Hikma Pharmaceuticals shares continued their downward spiral as HSBC slashed their target price, telling clients its first half numbers contained lower guidance for generics and a tougher outlook for injectables and branded drugs.

14:56 Calpine agrees to be acquired for $5.6bn in cash

Shares of Calpine Corporation surged after news broke that the American power generation company had agreed to be acquired by a consortium led by Energy Capital Partners.

14:27 FTSE 100 movers: Airline shares down after Barcelona attack; Upgrade boost for Mondi, RSA

The Barcelona attack and disintegrating relationship between US President Donald Trump and the business community made for a very heavy splash of red among the Footsie on Friday.